EU Agency Recommends GlaxoSmithKline Kidney Cancer Drug
Published: Feb 19, 2010
Reuters -- European regulators recommended GlaxoSmithKline's new kidney cancer drug Votrient for conditional approval on Friday, paving the way for its rollout across the European Union.